AI-generated draft from CMS source. Review and verify clinical accuracy before use.
CLINICAL STAGE / CARE PATHWAY
Patient is currently in the therapeutic intervention phase of care for sacroiliac joint pain after persistence of symptoms for at least three months despite prior conservative management, with clinical findings and diagnostic imaging supporting progression to sacroiliac joint injection procedure with image guidance.
– Sequencing logic: Diagnostic sacroiliac joint injection should precede therapeutic injections, with a diagnostic injection demonstrating ≥75% pain relief to support proceeding to therapeutic SIJI. Therapeutic injections may be repeated based on clinical response up to four sessions per rolling 12 months.
ICD-10 / DIAGNOSIS SUPPORT
Diagnosis support includes sacroiliitis, sacral spondylosis, sacrococcygeal disorders, or fusion disorders consistent with sacroiliac joint pain presentation and supporting the requested sacroiliac joint injection.
The documented diagnosis correlates with patient history, exam findings including provocative SI joint maneuvers, imaging, and response to prior treatments.
– Example ICD-10 options:
M46.1 – Sacroiliitis, not elsewhere classified
M47.818 – Spondylosis without myelopathy or radiculopathy, sacral and sacrococcygeal region
M43.28 – Fusion of spine, sacral and sacrococcygeal region
M53.3 – Sacrococcygeal disorders, not elsewhere classified
SUBJECTIVE / HPI SUPPORT
Patient reports moderate to severe low back pain localized primarily over the anatomical sacroiliac joint area between the iliac crests and the gluteal fold, persisting for at least three months, with exacerbation by weight-bearing, sitting, standing, and movement affecting activities of daily living and quality of life.
Symptoms have not substantially improved despite conservative care measures.
– Edit if needed:
greater than 3 months
unilateral left-sided pain
unilateral right-sided pain
bilateral sacroiliac pain
CONSERVATIVE CARE / PRIOR TREATMENT
Patient has undergone a minimum of four weeks of conservative therapy including physical therapy, physician-directed home exercise program, activity modification, and appropriate medication management without adequate sustained symptom relief.
– Common conservative care examples:
Physical therapy focusing on pelvic stabilization
Home exercise program targeting SI joint stabilization
NSAID therapy
Activity modification to reduce SI joint strain
Prior analgesic medication trials
OBJECTIVE / DIAGNOSTIC SUPPORT
Physical exam reveals at least three positive SI joint provocative tests such as FABER, Gaenslen, Thigh Thrust, Posterior Shear, SI Compression, SI Distraction, or Yeoman tests indicating sacroiliac joint dysfunction.
Imaging including fluoroscopy or CT confirms accurate needle placement and intraarticular injection with contrast.
No alternative lumbar or pelvic pathology is identified that better explains patient’s symptoms.
ASSESSMENT
Assessment: Persistent sacroiliac joint pain consistent with clinical, imaging, and diagnostic injection findings. The patient demonstrates functional impairment and incomplete response to conservative measures. Diagnostic SI joint injection produced significant temporary pain relief consistent with SIJ as pain generator, supporting therapeutic intervention.
PLAN / NEXT STEP
Plan: Proceed with fluoroscopy or CT-guided sacroiliac joint injection using anesthetic and corticosteroid agents. Patient consented regarding risks, benefits, and alternatives. The procedure will target the clinically relevant sacroiliac joint(s) based on symptom localization and prior diagnostic injection response. Follow-up scheduled to assess pain relief and function.
– Edit if needed:
unilateral right-sided SI joint
unilateral left-sided SI joint
bilateral SI joints
PROCEDURE-SPECIFIC CLINICAL REQUIREMENTS
The SI joint injection is performed under fluoroscopic or CT image guidance with the use of contrast to confirm intraarticular placement unless contraindicated by allergy or pregnancy, in which case ultrasound guidance without contrast may be considered.
Prior diagnostic SI joint injection documented ≥75% sustained pain relief measured by the same pain scale pre- and post-procedure supports proceeding to therapeutic injection.
Therapeutic SIJI are supported if prior injection yielded consistent ≥50% pain relief or ≥50% functional improvement in previously painful movements or ADLs for at least three months compared to baseline using the same validated pain scale and functional assessment tools.
No concurrent musculoskeletal injections of the lumbosacral spine during SIJI session or efficacy assessment period.
FOLLOW-UP / RESPONSE DOCUMENTATION
Patient reports at least 50% sustained pain relief and improved ability to perform activities of daily living for a minimum of three months after therapeutic SI joint injection as compared to baseline assessments.
Pain reduction and functional improvement are corroborated using the same pain scale and functional assessment tools used at baseline.
– Edit if needed:
greater than 80% improvement
relief lasting several months
MISSING DOCUMENTATION CHECK
– Documentation items to confirm:
Symptom duration of at least 3 months
Documentation of ≥3 positive SI joint provocative tests
Prior conservative care including ≥4 weeks of therapy
Baseline and post-injection pain score on same validated scale
Percent pain relief and duration documented for diagnostic and therapeutic SIJI
Imaging confirmation of needle placement with contrast under fluoroscopy or CT
Functional improvement measures for therapeutic injections
Diagnosis and ICD-10 correlation
APPEAL / PEER-TO-PEER CLINICAL SUPPORT
The requested sacroiliac joint injection procedure is clinically supported by the documented diagnosis of sacroiliac joint pain, positive physical examination, imaging confirmation, failed conservative management, and positive diagnostic injection providing significant pain relief. The care continuum supports medical necessity for proceeding with the therapeutic injection under image guidance.
The clinical evidence in the record demonstrates consistent functional limitation and symptom severity to justify intervention and is aligned with established care standards and coverage criteria.
– Common workflow:
Perform diagnostic SI joint injection with image guidance → Confirm ≥75% pain relief → If positive, proceed to therapeutic SIJI → Assess functional gain and ≥50% pain reduction → Repeat therapeutic SIJI as clinically indicated within limits.
COVERED PROCEDURES AND SERVICES
– Sacroiliac joint injections (SIJI) performed under CT or fluoroscopy guidance with contrast; ultrasound guidance with no contrast permitted only for documented contrast allergy or pregnancy.
– CPT codes: 27096 (injection procedure for SI joint with imaging), 64451 (nerve injections innervating SI joint with imaging), G0260 (SIJ injection for ASC or OPPS facility reporting).
– Bilateral procedures allowed same session; bilateral injections reported with modifier 50 on professional claims; ASC facilities use separate lines with -LT and -RT, no modifier 50.
– Do not report CPT 27096 and 64451 for the same side during same session.
– Diagnostic SIJI require ≥75% pain relief per same pain scale pre/post injection to confirm pain source; no more than two diagnostic sessions per rolling timeframe.
– Therapeutic SIJI require baseline positive diagnostic response, ≥50% consistent pain or functional ADL improvement for ≥3 months post-injection; no more than 4 therapeutic sessions per 12 months.
– SIJ denervation (radiofrequency ablation) is not covered.
INDICATIONS AND MEDICAL NECESSITY
– Moderate to severe low back pain localized to SI joint region lasting ≥3 months, below L5 without radiculopathy.
– Exclude other causes like spinal stenosis, disc herniation, fractures, infection, tumor, pseudoarthrosis or pain from instrumentation.
– At least 3 positive provocative SIJ maneuvers.
– Pain must persist despite ≥4 weeks conservative therapy and patient actively participating in rehabilitation/home exercise programs.
DOCUMENTATION REQUIREMENTS
– Complete documentation of indications, medical necessity and pain assessments using same validated pain scale pre-procedure, immediately post-procedure, and during follow-up.
– Record percent pain relief with duration consistent with local anesthetic and steroid pharmacodynamics.
– Functional assessment when ADL improvements claimed, using validated objective scales with measurable goals.
– Radiographic imaging documentation with at least two views demonstrating needle position and contrast flow for intraarticular confirmation.
– All documentation must be legible, signed, dated and maintained for audit.
BILLING AND CODING GUIDANCE
– Use CPT 27096 and 64451 with modifier 50 for bilateral professional services; do not report both on same side.
– For ASC/OPPS, CPT 27096 not covered; report G0260 with image guidance evidence.
– CPT 64451 includes imaging guidance, do not separately report imaging codes.
– For non-image-guided injections (no contraindication for contrast), use CPT 20552 instead of 27096/64451.
– KX modifier required on initial diagnostic SIJI claims; no repeat diagnostic injections beyond first two sessions after treatment initiation.
– No biologics (platelet rich plasma, stem cells, amniotic fluid, placenta-derived injectables) allowed; use may trigger claim denials.
UTILIZATION AND LIMITATIONS
– Maximum of 2 diagnostic SIJI sessions total (unilateral or bilateral).
– Maximum of 4 therapeutic SIJI sessions per rolling 12 months (unilateral or bilateral).
– SIJI beyond 12 months generally not reasonable unless documented severe disability, ≥50% sustained pain/function improvement, high surgical risk, or surgery refusal with appropriate multidisciplinary oversight.
– Deep sedation, general anesthesia, or MAC typically not medically necessary for SIJIs; oral anxiolytics preferred if needed.
– Multiple injections (epidural, facet, sympathetic blocks) not allowed during same session as SIJI or during post-injection efficacy period.
PROVIDER QUALIFICATIONS
– Providers must be appropriately trained/credentialed via accredited residency/fellowship or recognized certification programs including procedure performance and management.
– Services must be within provider’s licensure and scope of practice.
DENIAL AND AUDIT RISKS
– Claims lacking documentation of image guidance and contrast use if required.
– Failure to document ≥75% diagnostic pain relief or ≥50% therapeutic pain/function improvement with validated scales.
– Claims for SIJ denervation (RFA) or biologic injectables are not payable.
– Reporting both CPT 27096 and 64451 for same side during same session or improper bilateral modifier use.
– Exceeding allowable diagnostic or therapeutic injection frequency limits.
– Lack of documentation supporting exclusion of other pain causes or conservative treatment failure.
– Lack of signed, legible and complete medical record supporting medical necessity.
IMAGING AND PROCEDURE SEQUENCING
– Image guidance with contrast required except documented contraindications for ultrasound without contrast.
– Diagnostic SIJI must precede therapeutic SIJI and demonstrate positive response for therapy to be reasonable and necessary.
– Separate injection sessions for diagnostic and therapeutic phases; simultaneous multiple SI-related injections disallowed.
NOT CLEARLY STATED IN SOURCE
– Specific billing frequency audits beyond the stated limits or potential preauthorization procedures.
– Details on provider qualification documentation submission or verification process.